Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 Patient characteristics

From: Preoperative endothelial dysfunction for the prediction of acute kidney injury after cardiac surgery using cardiopulmonary bypass: a pilot study based on a second analysis of the MONS study

Characteristics

AKI

No AKI

p value

N (%)

43 (71.7)

17 (28.3)

–

Male sex

42 (97.7)

14 (82.3)

0.03

Age at enrollment, years

68 [60–74]

66 [47–72]

0.38

Body mass index, kg/m2

27 [25–31]

25 [22–30]

0.07

Body weight, kg

80 [75–91]

70 [65–85]

0.03

Smokers

23 (53.5)

7 (41.2)

0.29

Medical conditions

Diabetes mellitus

13 (30.2)

4 (23.5)

0.60

Hypertension

25 (58.1)

6 (35.3)

0.11

Dyslipidemia

17 (39.5)

8 (47.1)

0.59

Angina

13 (30.2)

5 (29.4)

0.95

Peripheral artery disease

4 (9.3)

1 (5.9)

0.66

Left ventricle ejection fraction, %

65 [57–72]

60 [59–73]

0.71

Preoperative atrial fibrillation

9 (20.9)

1 (5.9)

0.16

Preoperative laboratory parameters

Cockcroft creatinine clearance, ml/min

103 [84–131]

111 [86–135]

0.47

Preoperative platelet count, G/l

215 [191–260]

245 [209–297]

0.17

Preoperative hemoglobinemia, g/dl

14.3 [13.7–15.3]

14.6 [13.4–15.2]

0.71

Preoperative CRP rate, mg/l*

4.6 [4.1–5.3]

4.1 [4–4]

0.39

Preoperative medications

Beta-blocker

30 (69.8)

11 (64.7)

0.70

ACE inhibitor or ARB

28 (65.1)

10 (58.8)

0.65

Antiplatelet therapy

30 (69.8)

11 (64.7)

0.70

Aspirin therapy

29 (67.4)

11 (64.7)

0.84

Dual antiplatelet therapy

16 (37.2)

5 (29.4)

0.57

Calcium channel blocker

6 (13.9)

2 (11.8)

0.82

Anticoagulant

9 (20.9)

1 (5.9)

0.16

Statin therapy

29 (67.4)

11 (64.7)

0.84

Elective CABG

22 (51.1)

8 (47.1)

0.95

Elective valvular surgery

21 (48.8)

9 (52.9)

0.77

EuroSCORE II

0.8 [0.7–1.2]

0.8 [0.6–0.9]

0.27

Cleveland Clinic Score

1.0 [0–1.0]

1.0 [0–1.5]

0.80

Intraoperative confounders

Duration of surgery, min

197 [181–254]

199 [141–242]

0.27

Duration of aortic clamping, min

75 [54–103]

57 [54–79]

0.16

Duration of CPB, min

101 [73–125]

83 [71–91]

0.08

Intraoperative norepinephrine, µg/kg/min (dose by weight by duration of CPB), n = 41

0.150 [0.095–0.265]

0.156 [0.054–0.213]

0.393

  1. Data are expressed as median [interquartile range] or number (percentage of the group)
  2. AKI acute kidney injury, ACE angiotensin-converting enzyme, ARB angiotensin II receptor blocker, CABG coronary arterial bypass grafting, CRP C-reactive protein, CPB cardiopulmonary bypass
  3. aLimit of detection < 4 mg/l
Back to article page

Perioperative Medicine

ISSN: 2047-0525